Novacyt seeks permission to test medicine for corona virus.

PARIS (Reuters) - A Biotechnolgoy Company created sensation in the share market as it claims to conduct a taste for corona virus, which has badly affected China and a medical threat to the whole world.

Novacyt, which is listed in Paris and London, also said it was in talks with public sector hospitals in Britain.

Its Paris-listed shares jumped by around 20 percent by 0830 GMT.

We have got a very good response from our new and existing customers Novacyt CEO Graham Mullis said.

We are working with the various regulatory authorities to try to make our nCoV test available to as many countries and laboratories as possible,” he added.

The death toll from the fast-spreading coronavirus in mainland China has reached 636, with 73 more deaths recorded as of Thursday, China’s National Health Commission said.

Courtesy : reuters